Loading
Video visits, remote monitoring and home delivery of some cancer treatments expanded massively during COVID-19 and have stayed; they reduce travel burden, especially for rural patients, without evidence of worse outcomes.
Telehealth use in oncology rose from ~1% to ~50% of visits at the 2020 peak and settled around 10-20%. Evidence: REACH PC (JAMA 2024) showed video palliative care equal to in-person; teleoncology models (Australia's Townsville, US rural networks) deliver chemotherapy supervision remotely; home infusion of some agents (subcutaneous daratumumab, pembrolizumab, trastuzumab-pertuzumab) and oral therapies with remote monitoring are growing; 'hospital-at-home' for febrile neutropenia and CAR-T monitoring is being piloted. Decentralised clinical trials use telehealth to broaden enrolment. Limits: broadband and digital literacy (the digital divide widens disparities), licensure across state lines, reimbursement parity, and the need for physical examination and imaging.
Substitute synchronous video or asynchronous digital contact and remote monitoring for in-person visits where physical assessment is not required, and move low-risk treatment and monitoring into the home.
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Two technology pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Query for this technology: (TITLE:"Telehealth and hospital-at-home in oncology" OR ABSTRACT:"Telehealth and hospital-at-home in oncology") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Telehealth and hospital-at-home in oncology, not a curated reading list.
Shares PROMIS: the item banks that let a short questionnaire be precise, The questionnaires that were never returned, and the people never asked, What has actually been implemented since those trials, and what has not, Asking people how they are, every week, as a treatment in its own right.
Shares OncoHealth, Reimagine Care.
Shares PROMIS: the item banks that let a short questionnaire be precise, The questionnaires that were never returned, and the people never asked, Asking people how they are, every week, as a treatment in its own right, Electronic patient-reported outcome (ePRO) symptom monitoring.
Shares Oncology workforce, Oncology nursing and nurse-led care, Financial toxicity and financial navigation, Global oncology and access in low- and middle-income countries.
Shares PROMIS: the item banks that let a short questionnaire be precise, Asking people how they are, every week, as a treatment in its own right, Electronic patient-reported outcome (ePRO) symptom monitoring.
Shares The questionnaires that were never returned, and the people never asked, Oncology nursing and nurse-led care, Global oncology and access in low- and middle-income countries.
Shares Telehealth in Oncology: ASCO Standards and Practice Recommendations, Where rehabilitation is commissioned, and who misses out.
Shares After treatment in Australia: a stated model of survivorship care, The questionnaires that were never returned, and the people never asked, Financial toxicity and financial navigation.